Overview
Radiometer develops, manufactures, and markets acute care diagnostic solutions including blood gas analyzers, immunoassay analyzers, transcutaneous monitors, blood sampling syringes, and integrated IT management systems. These products support blood gas, electrolyte, metabolite, cardiac, coagulation, infection, and pregnancy marker testing in hospitals, emergency departments, and intensive care units. As part of Danaher Corporation, Radiometer provides fast, accurate diagnostics to streamline workflows and improve patient care in point-of-care and central lab settings.
Frequently asked questions
- What diagnostic solutions does Radiometer offer for acute care?
- Radiometer offers blood gas analyzers, immunoassay analyzers for cardiac/coagulation/infection/pregnancy markers, transcutaneous monitors, blood sampling syringes, and point-of-care IT solutions to support critical testing in hospitals.
- What regulatory standards do Radiometer products meet?
- As a medical device company and Danaher subsidiary, Radiometer products comply with global medical device regulations for acute care diagnostics, including FDA standards in the US, with a focus on reliability in clinical settings.
- In which geographies does Radiometer operate?
- Radiometer operates globally with headquarters in Copenhagen, Denmark, a US presence via Radiometer America in Ohio, and serves hospitals worldwide, testing half a million blood samples daily.